Jyong Biotech Ltd. Ordinary Shares

MENS | NASDAQ

$1.89

+$0.01 (+0.53%)

Nov 2, 2026, 1:17 PM ET · Market open

Fiscal Quarter Period Ending	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Net Income	-1.71K	-1.71K	-846.50	-846.50	-663	-663	-1.33K
Depreciation & Amortization	n/a	n/a	29	29	31	31	31
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	163	163	-906.50	-906.50	472
Other Non-Cash Items	1.71K	1.71K	-912.35K	229	-2.71M	152	171.50
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	163	163	-906.50	-906.50	472
Operating Cash Flow	n/a	n/a	-913K	-425.50	-2.71M	-1.39K	-654.50
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	951K	n/a	1.25M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-103K	424	-110K	571	657.50
Financial Cash Flow	n/a	n/a	848K	424	1.14M	571	657.50
Net Cash Flow	1.04M	n/a	2K	n/a	99K	n/a	n/a
Free Cash Flow	n/a	n/a	-425.50	-425.50	-1.39K	-1.39K	-654.50
Adj. Free Cash Flow	n/a	n/a	-425.50	-425.50	-1.39K	-1.39K	-654.50
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	n/a	n/a	-425.50	-425.50	-1.39K	-1.39K	-654.50